Cell-processing procedures are conducted in accordance with Good Manufacturing Practices, and clinical procedures are performed by highly optimised methods. A highquality transportation system is essential for safe and efective handling of mesenchymal stem cells (MSCs) between cell-processing and transplantation stages. For MSC transportation, either frozen cell or non-frozen cell transportation is performed. There are many requirements for transporting a package by either type of transportation. In frozen cell transportation, some issues have yet to be resolved: the primary receptacle and cryoprotectant reagents. In non-frozen cell transportation, control of cell metabolism and protection from environmental changes are more serious problems. Stabilisation of temperature, shock resistance, gas control, and an ultraviolet radiation (UVR) shielding technology should be considered. The transportation system should be established in compliance with the guidelines. Both development of a high-quality transportation package and establishment of a high-quality transportation system are important for the efective use of MSCs in clinical applications.